Literature DB >> 16769542

Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series.

Y Patrice Le Treut1, Jean Hardwigsen, Pascal Ananian, Jean Saïsse, Emilie Grégoire, Hubert Richa, Pierre Campan.   

Abstract

Tumor thrombus in major vasculature is a frequent finding with a poor long-term prognosis in patients with hepatocellular carcinoma (HCC). The utility of surgical resection is still controversial. This study compared morbidity and survival after resection for HCC with and without tumor thrombus. Data of 108 patients who underwent major hepatic resection for HCC were prospectively recorded. Patients were divided into two groups. The venous thrombectomy (VT) group included 26 patients who had HCC with tumor thrombus in the portal or hepatic veins. The matched control group included 82 patients who had HCC without tumor thrombus. Surgical technique, early outcome, and late survival were analyzed in each group. Multivariate analysis was performed to assess the prognostic value of this feature. Surgical technique was comparable in the VT and control group with regard to extent of hepatectomy, procedure duration, and transfusion requirements. Early postoperative outcome was also comparable. Actuarial survival at 1, 3, and 5 years was 38%, 20%, and 13%, respectively, in the VT group (median: 9 months) versus 74%, 56%, and 33%, respectively, in the control group (median: 41 months). In the subgroup of patients with tumor thrombus limited to the portal vein, actuarial survival at 1, 3, and 5 years was 50%, 26%, and 17%, respectively, (median: 12 months) and two patients lived longer than 5 years. Multivariate analysis showed that incomplete resection, alphafetoprotein level greater than 100 N, more than two tumor nodules, and tumor thrombus in major vasculature were independent factors of poor prognosis. Survival after resection for HCC with tumor thrombus in the major vasculature is poorer than after resection for HCC without tumor thrombus. However, an aggressive surgical strategy can provide significant survival with comparable morbidity in selected cases, that is, tumor thrombus located in the portal vein only and expected complete resection of the lesions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16769542     DOI: 10.1016/j.gassur.2005.12.011

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  30 in total

1.  Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function.

Authors:  H Tanaka; K Hirohashi; S Kubo; T Shuto; I Higaki; H Kinoshita
Journal:  Br J Surg       Date:  2000-07       Impact factor: 6.939

Review 2.  Prognostic prediction and treatment strategy in hepatocellular carcinoma.

Authors:  Jordi Bruix; Josep M Llovet
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

Review 3.  Surgical resection of hepatocellular carcinoma. Post-operative outcome and long-term results in Europe: an overview.

Authors:  Daniel Jaeck; Philippe Bachellier; Elie Oussoultzoglou; Jean-Christophe Weber; Philippe Wolf
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

4.  Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.

Authors:  J M Llovet; J Bustamante; A Castells; R Vilana; M del C Ayuso; M Sala; C Brú; J Rodés; J Bruix
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

5.  Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value.

Authors:  G L Grazi; G Ercolani; F Pierangeli; M Del Gaudio; M Cescon; A Cavallari; A Mazziotti
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

6.  No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach.

Authors:  G Torzilli; M Makuuchi; K Inoue; T Takayama; Y Sakamoto; Y Sugawara; K Kubota; A Zucchi
Journal:  Arch Surg       Date:  1999-09

7.  Liver resection for hepatocellular carcinoma (HCC) with direct removal of tumor thrombi in the main portal vein.

Authors:  Y Yamaoka; K Kumada; K Ino; T Takayasu; Y Shimahara; K Mori; A Tanaka; T Morimoto; Y Taki; M Washida
Journal:  World J Surg       Date:  1992 Nov-Dec       Impact factor: 3.352

8.  Major liver resections for hepatocellular carcinoma on cirrhosis: early and long-term outcomes.

Authors:  Lorenzo Capussotti; Andrea Muratore; Paolo Massucco; Alessandro Ferrero; Roberto Polastri; Hedayat Bouzari
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

Review 9.  The surgical approach to HCC: our progress and results in Japan.

Authors:  Masatoshi Makuuchi; Keiji Sano
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

10.  Portal vein embolization before right hepatectomy: prospective clinical trial.

Authors:  Olivier Farges; Jacques Belghiti; Reza Kianmanesh; Jean Marc Regimbeau; Roberto Santoro; Valérie Vilgrain; Alban Denys; Alain Sauvanet
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

View more
  49 in total

1.  Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging.

Authors:  Tian Yang; Chuan Lin; Jian Zhai; Song Shi; Min Zhu; Nan Zhu; Jun-Hua Lu; Guang-Shun Yang; Meng-Chao Wu
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-10       Impact factor: 4.553

2.  Factors linked to longterm survival of patients with hepatocellular carcinoma accompanied by tumour thrombus in the major portal vein after surgical resection.

Authors:  Rumi Matono; Shohei Yoshiya; Takashi Motomura; Takeo Toshima; Hiroto Kayashima; Toshiro Masuda; Tomoharu Yoshizumi; Akinobu Taketomi; Ken Shirabe; Yoshihiko Maehara
Journal:  HPB (Oxford)       Date:  2012-02-03       Impact factor: 3.647

3.  Outcomes of surgical resection and loco-regional therapy in patients with stage 3A hepatocellular carcinoma: a retrospective review from the national cancer database.

Authors:  Ramanathan M Seshadri; Erin H Baker; Megan Templin; Ryan Z Swan; John B Martinie; Dionisios Vrochides; David A Iannitti
Journal:  HPB (Oxford)       Date:  2015-08-14       Impact factor: 3.647

Review 4.  Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus.

Authors:  Masami Minagawa; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

5.  Edmondson-Steiner grading increases the predictive efficiency of TNM staging for long-term survival of patients with hepatocellular carcinoma after curative resection.

Authors:  Li Zhou; Jing-An Rui; Da-Xiong Ye; Shao-Bin Wang; Shu-Guang Chen; Qiang Qu
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

6.  Adjuvant hepatic arterial infusion chemotherapy after hepatic resection of hepatocellular carcinoma with macroscopic vascular invasion.

Authors:  Hidetoshi Nitta; Toru Beppu; Katsunori Imai; Hiromitsu Hayashi; Akira Chikamoto; Hideo Baba
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

Review 7.  Management of hepatocellular carcinoma with portal vein thrombosis.

Authors:  Matthew Quirk; Yun Hwan Kim; Sammy Saab; Edward Wolfgang Lee
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 8.  Outcomes of surgery for hepatocellular carcinoma with tumor thrombus in the inferior vena cava or right atrium.

Authors:  Kazuhiko Sakamoto; Hiroaki Nagano
Journal:  Surg Today       Date:  2017-12-26       Impact factor: 2.549

9.  Surgical resection versus conformal radiotherapy combined with TACE for resectable hepatocellular carcinoma with portal vein tumor thrombus: a comparative study.

Authors:  Qing-he Tang; Ai-jun Li; Guang-ming Yang; Eric C H Lai; Wei-ping Zhou; Zhi-hao Jiang; Wan Yee Lau; Meng-chao Wu
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

10.  Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.

Authors:  Brian I Carr; Vito Guerra
Journal:  Dig Dis Sci       Date:  2015-11-17       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.